Skip to main content
. 2018 May 8;293(25):9604–9613. doi: 10.1074/jbc.RA118.002838

Figure 2.

Figure 2.

Hyperpolarized [1-13C]pyruvate 13C magnetic resonance spectra from mouse hearts treated with PDK inhibitors. A, lean mouse. B, DIO mouse with DMSO control. C, DIO mouse with PS-10. D, DIO mouse with DCA. The numbers denote metabolite signals as follows: 1, [1-13C]aspartate; 2, [4-13C]aspartate; 3, [4-13C]malate; and 4, [1-13C]malate.